Background: Receptor tyrosine kinases (RTKs) regulate the proliferation, differentiation and metabolism of cells, and play key roles in tissue repair, tumorigenesis and development. To facilitate the study of RTKs, we have made conditional alleles that encode monomeric forms of the normally heterotetrameric insulin receptor and monomeric platelet-derived growth factor (PDGF) β receptors fused to the FK506-binding protein 12 (FKBP12). The chimeric receptors can be induced to undergo dimerization or oligomerization by a small synthetic molecule called FK1012, and the consequences were studied in cells and embryonic tissues.
Background
A generally applicable method for the activation of cellular proteins using small organic molecules called chemical inducers of dimerization (CIDs) has been developed. CIDs have thus far been derived primarily from FK506, cyclosporin, and rapamycin. These natural products and their synthetic derivatives bind to the natural and mutant immunophilin domains FK506-binding protein 12 (FKBP12), cyclophilin, and the FKBP12-rapamycinbinding (FRB) domain of FKBP-rapamycin associated protein (FRAP) [1] . By using the appropriate CIDs to trigger the dimerization or oligomerization of functional domains of various proteins that are fused to immunophilin dimerization domains, it has been possible to achieve small-molecule control of signaling mediated by the T-cell receptor [2, 3] , Fas [4, 5] , cadherin [6] and erythropoietin receptor [7] , and by the intracellular proteins Src [8] , Sos [9] , Raf [10] , and ZAP70 [11] . In addition, CIDs have been used to inducibly translocate proteins to the plasma membrane [8, 9, 12] and into [12] and out of [13] the nucleus, and to regulate gene transcription [12, 14] . The system has also been used successfully to induce cell-specific apoptosis and to achieve regulated synthesis of human growth hormone in mice [5, 15] .
We have extended this approach to the study of two members of the receptor tyrosine kinase (RTK) family. These kinases control cellular proliferation, differentiation and metabolism and have pleiotropic roles in various physiological and pathological processes [16] . Extensive studies in recent years have illustrated the principles of RTK activation and signal transduction, yet questions regarding the roles of RTKs in normal and disease processes, and the roles and interactions of individual signaling pathways emanating from specific RTKs remain unanswered. Conditional alleles of RTKs controlled by cell-permeable CIDs should facilitate a greater understanding of the functions of RTKs.
Results and discussion
Conditional forms of the PDGF β and insulin receptors (designated MF pk 3PE and MF pk 3IRE, respectively) were generated by constructing plasmids that encoded chimeric proteins containing the myristoylation sequence from v-Src fused to three tandem copies of F pk , a mutant version of FKBP12 that fails to interact with calcineurin [12, 17] , followed by the full cytoplasmic tails of the PDGF β receptor (residues 558-1106) or insulin receptor (residues 942-1343), and by the glu-glu (EE) epitope tag ( Figure 1a ) [18] . ∆MF pk 3PE is a cytosolic form of MF pk 3PE with an amino-terminal Gly→Ala mutation in the v-Src myristoylation sequence that prevents myristoylation of the protein. MF pk 3P KR E is a kinase-deficient variant of MF pk 3PE with a Lys643→Arg mutation in the ATP-binding domain of the PDGF β receptor segment. Figure 1b illustrates schematically the activation mechanism of the wild-type PDGF β and insulin receptors by their respective protein ligands, compared with that of the engineered receptors by the cell-permeable CID. The wild-type PDGF β receptor is a monomeric transmembrane protein activated by ligand-induced dimerization and transphosphorylation after binding to a bivalent PDGF BB molecule [16, 19] . The insulin receptor is a disulfide-bonded heterotetrameric transmembrane protein believed to be activated by an insulin-induced change in the orientation of the active sites of the kinase domains, although the exact mechanism remains unclear [20] . In contrast, our engineered chimeric RTKs, which lack the extracellular ligandbinding and transmembrane domains, attach to the plasma membrane intracellularly via an amino-terminal myristoicamide moiety and are activated by CIDs such as FK1012 that trigger the dimerization or oligomerization of the chimeric receptors by binding to two FKBP12 domains simultaneously [1, 2, [4] [5] [6] [7] [8] [9] [10] 12, 14, 21, 22] .
To test whether the chimeric PDGF β receptor is activated by FK1012, we assayed for autophosphorylation of MF pk 3PE in the presence of FK1012. Human embryonic kidney (HEK) 293 cells were transfected with MF pk 3PE, treated with various doses of FK1012 for 25 minutes, and harvested for immunoblot analysis. As shown in Figure 2a , FK1012 induced the autophosphorylation of MF pk 3PE in a dose-dependent manner, which was detected in wholecell lysates by an anti-phosphotyrosine antibody, 4G10 (Anti-PY). Analysis with an anti-EE-tag antibody (Anti-EE) [18] revealed equivalent levels of expression of the chimeric receptor among all samples. Next, we compared the kinetics of FK1012-induced autophosphorylation of MF pk 3PE to those of PDGF BB-mediated autophosphorylation of an EE-tagged wild-type PDGF β receptor (PDGFRβE) (Figure 2b ). PDGF BB induced the rapid 14) ; ∆M, a mutant form of the myristoylation sequence with a substitution Gly2→Ala that abolishes the myristoylation site; F pk , human FKBP12 with mutations Gly89→Pro and Ile90→Lys [12, 17] (the copy number of F pk is indicated by the number following the fragment designation); P and IR, the complete cytoplasmic domains of the human PDGF β receptor (residues 558-1106) and of the β chain of the insulin receptor (residues 942-1343), respectively; E, Glu-Glu (EE) epitope tag; EC and TM, the extracellular and transmembrane domains, respectively, of the wild-type PDGF β receptor; P KR , a kinase-deficient mutant (Lys643→Arg) of the PDGF β receptor. (b) Schematic representation of the activation of the insulin and PDGF β receptors by their respective protein ligands or by a cell-permeable CID. autophosphorylation of PDGFRβE followed by the rapid down-regulation of the activated receptor; FK1012 brought about a similar, albeit slightly slower, response from MF pk 3PE. Such a delay has been observed previously in other FK1012-dependent processes [3] . The data in Figure 2c illustrate further the down-regulation of the chimeric receptor. HEK293 transfectants were treated with (lanes 2-4) or without (lane 1) 1 µM FK1012 for 30 min, then washed and chased in fresh medium for the indicated times. The signal decreased significantly after 1 hour (lane 3) and reduced to the basal level (lane 1) after 4 hours (lane 4). Similar down-regulation of receptor phosphorylation was observed in cells that had been treated with FK1012 for 4 hours (lane 5). Thus, the chimeric PDGF β receptor retains the ability to be down-regulated, indicating that the extracellular and transmembrane domains of the PDGF β receptor are not essential for this process. This result is consistent with previous findings showing that the kinase domains and the carboxy-terminal sequences of RTKs are involved in mediating receptor down-regulation via endocytosis [23] .
To check whether the chimeric PDGF β receptor was able to signal to downstream targets, we examined the activation of p70 S6k by MF pk 3PE; the pathway leading to the activation of this kinase emanates from the PDGF β receptor and other RTKs [24, 25] . We co-transfected MF pk 3PE (or control chimeras) and a plasmid encoding a hemagglutinin (HA)-tagged rat p70 S6 kinase (HA-p70 S6k ) into HEK293 cells. The cells were treated with or without 1 µM FK1012 for 25 minutes as indicated in Figure 3 before being harvested for an in vitro kinase assay (as described in Materials and methods). In cells transfected with MF pk 3PE, FK1012 stimulated p70 S6k activity, whereas it had no effect on cells transfected with MF pk 3E, a control construct lacking the cytoplasmic tail of the PDGF β receptor, nor on cells transfected with MF pk 3P KR E, a control construct lacking kinase activity. FK1012 alone had no effect on p70 S6k activity ( Figure 3a) . Figure 3b shows that MF pk 3PE and the wild-type PDGF β receptor are similarly effective in activating p70 S6k and that rapamycin completely inhibits their activity, suggesting that the chimeric and wild-type PDGF receptors share the same FRAP-mediated pathway that leads to the activation of p70 S6k [24, 25] . As described later (see below), MF pk 3PE was also found to activate MAP kinase in the presence of FK1012. These results suggest that the chimeric PDGF β receptor is able to signal normally through its downstream signal transduction pathways.
PDGF receptor signaling is involved in a variety of physiological and pathological processes, including neoplastic transformation and embryogenesis [16, 19] . During vertebrate development, PDGF α receptor signaling is required for gastrulation of Xenopus laevis and mice, and for the development of mesenchyme-derived tissues such as the craniofacial structure, and of septal structures of the heart in mice [26] [27] [28] ; however, PDGF β receptor signaling is essential for development of the cardiovascular, hematopoietic and renal systems in mice [29] . Conditional forms of RTKs such as MF pk 3PE should allow temporal and spatial issues concerning the requirement for RTK signaling during embryonic development to be explored. We therefore tested whether MF pk 3PE could be activated by FK1012 in embryonic tissue using Xenopus animal caps in mesoderm induction assays. Activated growth-factor receptors have been shown to induce Xenopus presumptive ectoderm to form mesoderm [30] . We first introduced the mRNAs encoding MF pk 3PE or control chimeric receptors into two-cell stage Xenopus embryos [31] and then explanted animal caps at stage 8. The caps were cultured in the presence or absence of the appropriate ligands until stage 35 when they were fixed and processed for staining with hematoxylin-eosin. FK1012 (1 µM) induced the formation of loose mesenchymal tissue typical of ventral mesoderm [32] in animal caps injected with MF pk 3PE (Figure 4a ,b), whereas it had no effect on uninjected cap tissues (Figure 4g ,h), caps injected with the control construct MF pk 3E (Figure 4c,d) , or whole embryos (data not shown). MF pk 3PE showed no background activity in the absence of FK1012 (compare Figure 4b,h) . As a positive control, we confirmed that PDGF BB could induce the formation of mesoderm in animal caps injected with the wild-type PDGF β receptor (Figure 4e,f) .
The insulin receptor may be a special case of an RTK that could pose a challenge to the proximity-inducing effects of CIDs such as FK1012. The mature insulin receptor is a disulfide-bonded heterotetramer comprising two copies each of the α and β subunits. Insulin binding has been suggested to induce a conformational change that leads to receptor activation [20] . The mechanism by which this conformational change activates the receptor kinase is unclear, although it may function by juxtaposing the kinase subunits in much the same way that receptor dimerization leads to activation of the PDGF β receptor. Thus, we tested whether direct dimerization of the β subunits of the insulin receptor by FK1012 could activate insulin-receptor signaling.
We first determined whether the chimeric insulin receptor MF pk 3IRE could be activated by FK1012 at the receptor level by assaying for its autophosphorylation in HEK293 cells. As shown in Figure 5a , FK1012 (1 µM) induced dramatic tyrosine phosphorylation of MF pk 3IRE followed by rapid down-regulation of the activated receptor. We then investigated the phosphorylation of insulin receptor substrate-1 (IRS-1) by FK1012-dependent activation of MF pk 3IRE in HEK293 transfectants. FK1012 stimulated the phosphorylation of IRS-1 by MF pk 3IRE (Figure 5b , lanes 3,4) to levels comparable to those induced by the endogenous wild-type insulin receptor (Figure 5b, lanes  1,2) . The control construct MF pk 3E showed no activity ( Figure 5b, lanes 5,6) . When MF pk 3IRE was co-transfected with HA-p70 S6k into HEK293 cells and the cells were treated with varying doses of FK1012 for 20 minutes, MF pk 3IRE activated p70 S6k in an FK1012 dose-dependent fashion (Figure 6a) . A high dose of FK1012 (3 µM) appeared to reduce p70 S6k activity, possibly because of the disruption of the dimeric receptor complex ('dedimerization') by excessive amounts of FK1012 (Figure 6a ). We also examined the activation of MAP kinase by MF pk 3IRE in HEK293 cells that had been co-transfected with MF pk 3IRE and HA-tagged human extracellularsignal-regulated kinase 1, ERK1 (HA-ERK1). As was observed for p70 S6k , MAP kinase could be activated by the chimeric insulin receptor in the presence of FK1012 (Figure 6b ). The control construct MF pk 3E had no effect on MAP kinase activity either in the presence or in the absence of FK1012. These results demonstrate that dimerization or oligomerization of the β subunits of the insulin receptor is sufficient to activate insulin receptor signaling, consistent with previous studies on other chimeric insulin receptors [33, 34] . The recruitment of Src homology 2 (SH2) domain-containing cytoplasmic proteins such as the p85 subunit of phosphoinositide 3′ kinase, Shc, Grb2, and phospholipase Cγ [35] to the membrane-inserted, phosphorylated -activated -receptor is believed to be a critical step in RTK signal transduction. This process results in a high effective molarity of the recruited proteins in the vicinity of their membrane-localized substrates, and thereby facilitates the ligand-dependent chemistry that takes place between them. To test this model by determining whether membrane attachment of an RTK is essential for downstream signal transduction, we prepared a cytosolic version of the chimeric PDGF β receptor ∆MF pk 3PE that lacks a myristoylation site (Figure 1a) . In HEK293 cells, FK1012 was able to induce the transphosphorylation of ∆MF pk 3PE receptor to a level similar to that seen with MF pk 3PE (Figure 7a) . ∆MF pk 3PE, however, failed to activate p70 S6 kinase appreciably in the presence of varying doses of FK1012, whereas MF pk 3PE elicited a near 10-fold stimulation (Figure 7b) . Likewise, FK1012-activated ∆MF pk 3PE had only marginal effects on MAP kinase activation, in contrast to the strong stimulation seen with FK1012-activated MF pk 3PE (Figure 7c ). Thus, membrane attachment appears to be essential for activated RTKs to link to downstream signal transduction pathways.
Conclusions
We have developed a small-molecule-based approach to activate insulin and PDGF β receptor chimeras conditionally using the FKBP12-FK1012 dimerization system [1, 2, [4] [5] [6] [7] [8] [9] [10] 12, 14, 21, 22] . In this study, we were able to use this system to induce mesoderm formation in Xenopus animal cap tissue and to demonstrate that membrane localization is required for RTK signaling in transfected cells. This strategy should allow the further dissection of RTK-mediated pathways in embryonic development and pathological processes, including oncogenesis and diabetes. Our data also suggest that dumbbell-shaped variants of small molecules comprising two receptor-binding elements connected by a covalent linkage and that bind directly to wild-type RTKs should be effective activators of these receptors.
Materials and methods

PCR conditions and primers
PCRs were carried out with native Pfu DNA polymerase (Stratagene) in the manufacturer's buffer for 25 cycles of 1 min at 94°C, 2 min at 55°C, and 3 min at 72°C. A cDNA fragment encoding the cytoplasmic domain of the PDGF β receptor was amplified with primers 5′-ACGCGTCGA-CAAGAAGCCACGTTACGAGATC-3′ and 5′-AATTTCTAGACTATTC-CATTGGCATGTATTCCAGGAAGCTATCCTCTGCTTC-3′. The latter primer also encodes the Glu-Glu epitope tag (EYMPME, single-letter amino-acid code) [18] . The cytoplasmic domain of the insulin receptor β chain was amplified with primers 5′-ATATACGCGTCGACAAGAG-GCAGCCAGATGGGCC-3′ and 5′-AAATCATAGTCGACGGAAG-GATTGGACCGAGGC-3′. The sequence of the PCR-generated products was verified by DNA sequencing.
Cell culture and transfection
HEK293 cells were seeded at a density of 3 × 10 5 cells per 60 mm dish in medium A (Dulbecco's modified Eagle's medium, 100 units/ml penicillin and 100 µg/ml streptomycin) supplemented with 10% (vol/vol) fetal calf serum (FCS). The following day (designated day 1), the cells were transfected by the calcium-phosphate method [36] . The total amount of DNA was adjusted to 5 µg per dish with the pJY2 vector, a derivative of pcDNA3 in which the three SalI sites were removed (provided by Brent Stockwell) and the multiple cloning sequence was replaced. On day 2 (24 h after transfection), the medium was replaced with fresh medium A supplemented with 10% (vol/vol) FCS. On day 3, the cells were washed with Hank's buffer and incubated in fresh medium A supplemented with 0.5% (vol/vol) FCS. On day 4 (after 24 h serum starvation), the cells were treated with various reagents and harvested for further analysis.
Immunoblot and kinase assays
For immunoblot analysis, aliquots (30 µg protein/lane) of cell lysate were separated by SDS-PAGE, transferred to Immobilon polyvinylidene difluoride membrane (Millipore), and blotted with appropriate antibodies. The immunocomplex was visualized by enhanced chemiluminescence (ECL) using an ECL detection system (Amersham). For the in vitro p70 S6k assay, cells were harvested in ice-cold MIPP buffer (20 mM NaH 2 PO 4 , pH 7.4, 1% Triton X-100, 25 µM β-glycerophosphate, 0.1 mM Na 3 VO 4 , 5 mM NaF, 2 mM EDTA, 2 mM EGTA, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 0.2 mM PMSF and 2 mM DTT). Half of the total-cell lysate from a 60 mm dish was incubated with 10 µg of 12CA5 anti-hemagglutinin monoclonal antibody at 4°C for 2 h and complexed to protein A-agarose beads at 4°C for 1 h. The precipitate was washed three times with MIPP buffer and once with kinase reaction buffer (50 mM MOPS, pH 7.2, 10 mM MgCl 2 , 10 mM para-nitrophenyl phosphate, 0.1% Triton X-100, 1 mM DTT) at 4°C. Immunoprecipitates were then incubated at 37°C for 20 min in 25 µl kinase reaction buffer containing 100 µM ATP, 10 µM [γ-32 P]ATP, 1 U/ml protein kinase inhibitor (Sigma), and 50 µM KRRRLASLAA peptide (single-letter amino-acid code) as substrate. The reaction was stopped by addition of 100 µM EDTA and incubation at 80°C for 2 min. The reaction mixtures were spotted onto P81 paper, subjected to four 5 min washes with 500 ml 0.85% H 3 PO 4 . The incorporated radioactivities were measured in a liquid scintillation counter. HAp70 S6k is a fusion of the HA epitope with the amino-terminus of rat p70 S6k [25] and its expression is driven by the cytomegalovirus (CMV) promoter. For the in vitro MAP kinase assay, cells were harvested in lysis buffer (20 mM Tris, pH 7.4, 25 mM β-glycerophosphate, 1 mM Na 3 VO 4 , 5 mM NaF, 2 mM EDTA, 1% NP-40, 10 µg/ml leupeptin, 10 µg/ml pepstatin, 0.2 mM PMSF and 2 mM DTT). HA-ERK1 was precipitated with 12CA5 monoclonal antibody as described for the p70 S6k assay. The precipitate was washed three times with the lysis buffer and once with kinase reaction buffer (20 mM Tris, pH 7.4, 10 mM MgCl 2 , 2 mM MnCl 2 ). Immunoprecipitates were incubated at 30°C for 30 min in 25 µl kinase reaction buffer containing 100 µM ATP, 50 µM [γ-32 P]ATP, 1 U/ml protein kinase inhibitor (Sigma), and 50 µg/ml APRTPGGRR peptide (single-letter amino-acid code) as substrate. The reaction mixtures were spotted onto P81 paper, washed and counted as described for p70 S6k . HA-ERK1 is a fusion of the HA epitope with the amino-terminus of human ERK1 and its expression is driven by the CMV promoter.
Xenopus mesoderm induction
The mRNA was synthesized with an SP6 mMESSAGE mMACHINE™ kit (Ambion). Xenopus embryos were microinjected at the two-cell stage with approximately 100 pg of synthetic mRNA. In the mesoderm induction assay, animal pole explants (caps) were prepared at stage 8. Explants were cultured in 0.75× MMR [37] with or without the various ligands until stage 35, then fixed in 4% paraformaldehyde, embedded in paraffin and sectioned. Histological sections were stained with hematoxylin-eosin.
Figure 7
Membrane localization is essential for signal transduction from the PDGF β receptor. (a) FK1012 activates engineered PDGF β receptors independent of membrane association. HEK293 cells were transfected with vector alone (V), MF pk 3PE or ∆MF pk 3PE. After starvation for 24 h, the cells were treated with the indicated amount of FK1012 for 25 min and harvested for immunoblot analysis with 4G10 antibody (Anti-PY) or with an anti-EE-tag antibody (Anti-EE). PDGF β receptor signaling to p70 S6k (b) and to MAP kinase (c) requires membrane localization of the receptor. HEK293 cells were transfected with the indicated plasmids, treated with or without FK1012 as shown, and subjected to in vitro kinase assays. Activities of p70 S6k Because Current Biology operates a 'Continuous Publication System' for Research Papers, this paper has been published on the internet before being printed. The paper can be accessed from http://biomednet.com/cbiology/cub -for further information, see the explanation on the contents page.
